日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting of phosphorylated tau at threonine 181 by a Qβ virus-like particle vaccine is safe, highly immunogenic, and reduces disease severity in mice and rhesus macaques.

通过 Qβ 病毒样颗粒疫苗靶向苏氨酸 181 处的磷酸化 tau 蛋白,是安全的,具有高度免疫原性,并能降低小鼠和恒河猴的疾病严重程度

Maphis Nicole M, Hulse Jonathan, Peabody Julianne, Dadras Somayeh, Whelpley Madelin J, Kandath Manas, Wilson Colin, Hobson Sasha, Thompson Jeff, Poolsup Suttinee, Beckman Danielle, Ott Sean P, Watanabe Jennifer W, Usachenko Jodie L, Van Rompay Koen K, Morrison John, Selwyn Reed, Rosenberg Gary, Knoefel Janice, Chackerian Bryce, Bhaskar Kiran

pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model.

在 rTg4510 tau 病模型中,pS396/pS404 (PHF1) tau 疫苗优于 pS199/pS202 (AT8)

Hulse Jonathan P, Maphis Nicole M, Peabody Julianne, Bondu Virginie, Chackerian Bryce, Bhaskar Kiran

Pathological tau activates inflammatory nuclear factor-kappa B (NF-κB) and pT181-Qβ vaccine attenuates NF-κB in PS19 tauopathy mice

病理性tau蛋白激活炎症性核因子-κB (NF-κB),而pT181-Qβ疫苗可减弱PS19 tau蛋白病小鼠中的NF-κB活性。

Tangavelou, Karthikeyan; Jiang, Shanya; Dadras, Somayeh; Hulse, Jonathan P; Sanchez, Kathryn; Bondu, Virginie; Villaseñor, Zachary; Mandell, Michael; Peabody, Julianne; Chackerian, Bryce; Bhaskar, Kiran